Cardiovascular Diseases

Nathoe HM, Koerselman J, Buskens E, van Dijk D, Stella PR, Plokker TH, Doevendans PA, Grobbee DE, de Jaegere PP; Octopus Study Group. Determinants and prognostic significance of collaterals in patients undergoing coronary revascularization. Am J Cardiol. 2006 Jul 1;98(1):31-5.

Peppelenbosch N, Geelkerken RH, Soong C, Cao P, Steinmetz OK, Teijink JA, Lepantalo M, De Letter J, Vermassen FE, DeRose G, Buskens E, Buth J. Endograft treatment of ruptured abdominal aortic aneurysms using the Talent aortouniiliac system: an international multicenter study. J Vasc Surg. 2006 Jun;43(6):1111-1123; discussion 1123.

Buskens E, Meijboom MJ, Kooijman H, Van Hout BA.The use of a surgical sealant (CoSeal(R)) in cardiac and vascular reconstructive surgery: an economic analysis. J Cardiovasc Surg (Torino). 2006 Apr;47(2):161-70.

Halkes PH, Wermer MJ, Rinkel GJ, Buskens E. Direct Costs of Surgical Clipping and Endovascular Coiling of Unruptured Intracranial Aneurysms. Cerebrovasc Dis. 2006;22(1):40-5.

van Stel HF, Buskens E.Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual Life Outcomes. 2006 Mar 25;4(1):20.

Buskens E. No nonagenarians please! Arch Surg. 2006 Jan;141(1):104.

Klein WM, van der Graaf Y, Seegers J, Spithoven JH, Buskens E, van Baal JG, Buth J, Moll FL, Overtoom TT, van Sambeek MR, Mali WP. Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement. Radiology. 2006 Feb;238(2):734-44.

Heijenbrok-Kal MH, Buskens E, Nederkoorn PJ, van der Graaf Y, Hunink MG. Optimal peak systolic velocity threshold at duplex us for determining the need for carotid endarterectomy: a decision analytic approach. Radiology. 2006 Feb;238(2):480-8.

Heeg B, van Gestel A, Hout B, Olsen J, Haghfelt TH. [Cost-effectiveness of clopidogrel vs. aspirin treatment in high-risk acute coronary syndrome patients in Denmark]. Ugeskr Laeger. 2006 Aug 28;168(35):2911-5. In Danish.

Mackey WC, Fleisher LA, Haider S, Sheikh S, Cappelleri JC, Lee WC, Wang Q, Stephens JM. Perioperative myocardial ischemic injury in high risk vascular surgery patients: Incidence and clinical significance in a prospective clinical trial. J Vasc Surg 2006;43; 533-8.

Buskens E. Endovascular repair of abdominal aortic aneurysm. Lancet. 2005 Sep 10-16;366(9489):890-1.

Heijenbrok-Kal MH, Nederkoorn PJ, Buskens E, van der Graaf Y, Hunink MG. Diagnostic performance of duplex ultrasound in patients suspected of carotid artery disease: the ipsilateral versus contralateral artery. Stroke. 2005 Oct;36(10):2105-9.

Wermer MJ, van der Schaaf IC, Velthuis BK, Algra A, Buskens E, Rinkel GJ; ASTRA Study Group. Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain. 2005 Oct;128(Pt 10):2421-9.

Blankensteijn JD, de Jong SE, Prinssen M, van der Ham AC, Buth J, van Sterkenburg SM, Verhagen HJ, Buskens E, Grobbee DE; Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2005 Jun 9;352(23):2398-405.

van Hout BA, Serruys PW, Lemos PA, van den Brand MJ, van Es GA, Lindeboom WK, et al. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart 2005 Apr;91(4):507-12.

Serruys PW, Lemos PA, van Hout BA; Arterial Revascularisation Therapies Study part II Steering Committee and Investigators. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II). Heart. 2004 Sep;90(9):995-8.

Legrand VM, Serruys PW, Unger F, van Hout BA, Vrolix MC, Fransen GM, Nielsen TT, Paulsen PK, Gomes RS, de Queiroz e Melo JM, Neves JP, Lindeboom W, Backx B; Arterial Revascularization Therapy Study (ARTS) Investigators. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation. 2004 Mar 9;109(9):1114-20.

Prinssen M, Buskens E, Tutein Nolthenius RP, van Sterkenburg SM, Teijink JA,Blankensteijn JD. Sexual Dysfunction After Conventional and Endovascular AAA Repair: Results of the DREAM Trial. J Endovasc Ther. 2004 Dec;11(6):613-20.

Prinssen M, Verhoeven EL, Buth J, Cuypers PW, van Sambeek MR, Balm R, Buskens E, Grobbee DE, Blankensteijn JD; Dutch Randomized Endovascular Aneurysm Management (DREAM)Trial Group. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004 Oct 14;351(16):1607-18.

Nathoe HM, Buskens E, Jansen EW, Suyker WJ, Stella PR, Lahpor JR, van Boven WJ, van Dijk D, Diephuis JC, Borst C, Moons KG, Grobbee DE, de Jaegere PP. Role of coronary collaterals in off-pump and on-pump coronary bypass surgery. Circulation. 2004 Sep 28;110(13):1738-42.

Buskens E, Nederkoorn PJ, Buijs-Van Der Woude T, Mali WP, Kappelle LJ, Eikelboom BC, Van Der Graaf Y, Hunink MG. Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology. 2004 Oct;233(1):101-12.

Prinssen M, Wixon CL, Buskens E, Blankensteijn JD. Surveillance after endovascular aneurysm repair: diagnostics, complications, and associated costs. Ann Vasc Surg. 2004 Jul;18(4):421-7.

Prinssen M, Buskens E, Blankensteijn JD; DREAM trial participants. Quality of life endovascular and open AAA repair. Results of a randomised trial. Eur J Vasc Endovasc Surg. 2004 Feb;27(2):121-7.

Maliwa MA, van der Heijden GJ, Bots ML, van Hout BA, Casselman FP, van Swieten H, Vermeulen FE. Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg. 2003 Oct;11(5):381-7.

Bax L, Mali WP, Buskens E, Koomans HA, Beutler JJ, Braam B, Beek FJ, Rabelink TJ, Postma CT, Huysmans FT, Deinum J, Thien T, Schultze Kool LJ, Woittiez AJ, Kouwenberg JJ, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Doorenbos CJ, Aarts JC, Kroon AA, de Leeuw PW, de Haan MW, van Engelshoven JM, Rutten MJ, van Montfrans GA, Reekers JA, Plouin PF, La Batide Alanore A, Azizi M, Raynaud A, Harden PN, Cowling M; STAR Study Group. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. J Nephrol. 2003 Nov-Dec;16(6):807-12.

Eefting F, Nathoe H, van Dijk D, Jansen E, Lahpor J, Stella P, Suyker W, Diephuis J, Suryapranata H, Ernst S, Borst C, Buskens E, Grobbee D, de Jaegere P. Randomized comparison between stenting and off-pump bypass surgery in patients referred for angioplasty. Circulation. 2003 Dec 9;108(23):2870-6.

Nathoe HM, van Dijk D, Jansen EW, Suyker WJ, Diephuis JC, van Boven WJ, de la Riviere AB, Borst C, Kalkman CJ, Grobbee DE, Buskens E, de Jaegere PP; Octopus Study Group. A comparison of on-pump and off-pump coronary bypass surgery in low-riskpatients. N Engl J Med. 2003 Jan 30;348(5):394-402.

Caprini JA, Botteman MF, Stephens JM, Nadipelli V, Ewing MM, Brandt S, Pashos CL, Cohen AT. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health. 2003 Jan-Feb;6(1):59-74.

ten Berg JM, Kelder JC, Plokker TH, van Hout BA. Costs and effectiveness of using coumarins before, during and after coronary angioplasty. Pharmacoeconomics. 2002;20(12):847-53.

Nederkoorn PJ, Mali WP, Eikelboom BC, Elgersma OE, Buskens E, Hunink MG, Kappelle LJ, Buijs PC, Wust AF, van der Lugt A, van der Graaf Y. Preoperative diagnosis of carotid artery stenosis: accuracy of noninvasive testing. Stroke. 2002 Aug;33(8):2003-8.

Prinssen M, Buskens E, Blankensteijn JD. The Dutch Randomised Endovascular Aneurysm Management (DREAM) trial. Background, design and methods. J Cardiovasc Surg (Torino). 2002 Jun;43(3):379-84.

van der Schaaf IC, Brilstra EH, Buskens E, Rinkel GJ. Endovascular treatment of aneurysms in the cavernous sinus: a systematic review on balloon occlusion of the parent vessel and embolization with coils. Stroke. 2002 Jan;33(1):313-8.

Botteman MF, Caprini J, Stephens JM, Nadipelli V, Bell CF, Pashos CL, Cohen AT. Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States. Clin Ther. 2002 Nov;24(11):1960-86; discussion 1938.

van Dijk D, Nierich AP, Jansen EW, Nathoe HM, Suyker WJ, Diephuis JC, van Boven WJ, Borst C, Buskens E, Grobbee DE, Robles De Medina EO, de Jaegere PP; Octopus Study Group. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation. 2001 Oct 9;104(15):1761-6.

Oostenbrink JB, Tangelder MJ, Busschbach JJ, van Hout BA, Buskens E, Algra A, Lawson JA, Eikelboom BC; Dutch Bypass Oral anticoagulants or Aspirin (BOA) Study Group. Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery. J Vasc Surg. 2001 Aug;34(2):254-62.

Zwart-van Rijkom JE, van Hout BA. Cost-efficacy in interventional cardiology; results from the EPISTENT study. Evaluation of Platelet IIb/IIIa Inhibitor For Stenting Trial. Eur Heart J. 2001 Aug;22(16):1476-84.

van Hout BA, Simoons ML. Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat? Eur Heart J. 2001 May;22(9):751-61.

Ruigrok YM, Buskens E, Rinkel GJ. Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke. 2001 May;32(5):1173-5.

Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA; Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001 Apr 12;344(15):1117-24.

Ruigrok YM, Rinkel GJ, Buskens E, Velthuis BK, van Gijn J. Perimesencephalic hemorrhage and CT angiography: A decision analysis. Stroke. 2000 Dec;31(12):2976-83.

Al MJ, Van Hout BA. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty. Health Econ. 2000 Oct;9(7):599-609.
Serruys PW, Unger F, van Hout BA, van den Brand MJ, van Herwerden LA, van Es GA, Bonnier JJ, Simon R, Cremer J, Colombo A, Santoli C, Vandormael M, Marshall PR, Madonna O, Firth BG, Breeman A, Morel MA, Hugenholtz PG. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Cardiol. 1999 Dec;4(4):209-19.

van Hout BA, Goes ES, Grijseels EW, van Ufford MA. Economic evaluation in the field of cardiology: theory and practice. Prog Cardiovasc Dis. 1999 Sep-Oct;42(2):167-73.

Raaymakers TW, Buys PC, Verbeeten B Jr, Ramos LM, Witkamp TD, Hulsmans FJ,Mali WP, Algra A, Bonsel GJ, Bossuyt PM, Vonk CM, Buskens E, Limburg M, van Gijn J, Gorissen A, Greebe P, Albrecht KW, Tulleken CA, Rinkel GJ. MR angiography as a screening tool for intracranial aneurysms: feasibility, test characteristics, and interobserver agreement. AJR Am J Roentgenol. 1999 Dec;173(6):1469-75.

Tangelder MJ, McDonnel J, Van Busschbach JJ, Buskens E, Algra A, Lawson JA, Eikelboom BC. Quality of life after infrainguinal bypass grafting surgery. Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group. J Vasc Surg. 1999 May;29(5):913-9.

van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, Koomans HA, Mali WP. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999 Jan 23;353(9149):282-6.

van Hout BA, Goes ES, Grijseels EW, Quarles van Ufford MA. [Economic evaluation of cardiology; background and application] Ned Tijdschr Geneeskd. 1998 Sep 19;142(38):2083-6. Dutch.

van Hout BA, Bowman L, Zelinger DJ, Simoons ML. Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications. Eur Heart J. 1998 Apr;19 Suppl D:D59-66.

Chronos N, Vahanian A, Betriu A, Emanuelsson H, Goldberg S, Gulba D, van Hout BA. Use of abciximab in interventional cardiology. Eur Heart J. 1998 Apr;19 Suppl D:D31-9.

van Hout BA, Bowman L, Zelinger DJ, Simoons ML. Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications. Am Heart J. 1998 Apr;135(4):S98-106.

Chronos N, Vahanian A, Betriu A, Emanuelsson H, Goldberg S, Gulba D, van Hout BA. Use of abciximab in interventional cardiology. Am Heart J. 1998 Apr;135(4):S67-76.

Buskens E, Steyerberg EW, Hess J, Wladimiroff JW, Grobbee DE. Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approach. Am J Public Health. 1997 Jun;87(6):962-7.

Van Hout BA, van der Woude T, de Jaegere PP, van den Brand M, van Es GA, Serruys PW, Morel MA. Cost effectiveness of stent implantation versus PTCA: the BENESTENT experience. Semin Interv Cardiol. 1996 Dec;1(4):263-8.

VandenBergh MF, Kluytmans JA, van Hout BA, Maat AP, Seerden RJ, McDonnel J, Verbrugh HA. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol. 1996 Dec;17(12):786-92.

Michel BC, Al MJ, Remme WJ, Kingma JH, Kragten JA, van Nieuwenhuizen R, van Hout BA. Economic aspects of treatment with captopril for patients with asymptomatic left ventricular dysfunction in The Netherlands. Eur Heart J. 1996 May;17(5):731-40.

Buskens E, Grobbee DE, Frohn-Mulder IM, Stewart PA, Juttmann RE, Wladimiroff JW, Hess J. Efficacy of routine fetal ultrasound screening for congenital heart disease in normal pregnancy. Circulation. 1996 Jul 1;94(1):67-72.

van Hout BA, Simoons ML. Costs and effects of c7E3 in high risk PTCA patients. An indirect analysis for The Netherlands. Eur Heart J. 1995 Nov;16 Suppl L:81-5.

de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JC, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol. 1995 Oct 15;76(11):830-3.

van Bergen PF, Jonker JJ, van Hout BA, van Domburg RT, Deckers JW, Azar AJ, Hofman A. Costs and effects of long-term oral anticoagulant treatment after myocardial infarction. JAMA. 1995 Mar 22-29;273(12):925-8.

Buskens E, Grobbee DE, Hess J, Wladimiroff JW. Prenatal diagnosis of congenital heart disease; prospects and problems. Eur J Obstet Gynecol Reprod Biol. 1995 May;60(1):5-11.

Buskens E, Grobbee DE, Frohn-Mulder IM, Wladimiroff JW, Hess J. Aspects of the aetiology of congenital heart disease. Eur Heart J. 1995 May;16(5):584-7.

van Hout BA, Wielink G, Bonsel GJ, Rutten FF. Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model. Pharmacoeconomics. 1993 May;3(5):387-97.

van Hout B, Bonsel G, Habbema D, van der Maas P, de Charro F. Heart transplantation in the Netherlands; costs, effects and scenarios. J Health Econ. 1993 Apr;12(1):73-93.

Burger H, Kootstra G, de Charro F, Leffers P. A survey of vascular access for haemodialysis in The Netherlands. Nephrol Dial Transplant 1991;6(1):5-10.